{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T20:06:32Z","timestamp":1766088392131,"version":"3.38.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/igo\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijid.2025.107791","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:24:09Z","timestamp":1738023849000},"page":"107791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Shrinking the lymphatic filariasis map of Zimbabwe: Reassessing the population requiring treatment through confirmatory mapping"],"prefix":"10.1016","volume":"152","author":[{"given":"Nicholas","family":"Midzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0868-1173","authenticated-orcid":false,"given":"Masceline Jenipher","family":"Mutsaka-Makuvaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Phiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Palatio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7471-3105","authenticated-orcid":false,"given":"Didier","family":"Bakajika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honorat M.","family":"Zour\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Juma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9776-1274","authenticated-orcid":false,"given":"Rebecca","family":"Mwabvu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4022-8603","authenticated-orcid":false,"given":"Moses J.","family":"Bockarie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9864-5058","authenticated-orcid":false,"given":"Jorge","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6309-476X","authenticated-orcid":false,"given":"Sammy M.","family":"Njenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"40","key":"10.1016\/j.ijid.2025.107791_bib0001","first-page":"565","article-title":"Global programme to eliminate lymphatic filariasis: progress report, 2023","volume":"99","year":"2024","journal-title":"Wkly Epidemiol Rec"},{"issue":"9747","key":"10.1016\/j.ijid.2025.107791_bib0002","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(10)60586-7","article-title":"Lymphatic filariasis and onchocerciasis","volume":"376","author":"Taylor","year":"2010","journal-title":"The Lancet"},{"doi-asserted-by":"crossref","unstructured":"Bockarie M.J. Reducing the population requiring interventions against lymphatic filariasis in Africa. 2016:1\u20132.","key":"10.1016\/j.ijid.2025.107791_bib0003","DOI":"10.1016\/S2214-109X(15)00292-2"},{"issue":"9747","key":"10.1016\/j.ijid.2025.107791_bib0004","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(10)60586-7","article-title":"Lymphatic filariasis and onchocerciasis","volume":"376","author":"Taylor","year":"2010","journal-title":"Lancet"},{"year":"1976","author":"Sasa","series-title":"Human filariasis: a global survey of epidemiology and control","key":"10.1016\/j.ijid.2025.107791_bib0005"},{"issue":"8","key":"10.1016\/j.ijid.2025.107791_bib0006","first-page":"649","article-title":"The distribution of human filariasis throughout the world. Part III","volume":"74","author":"Hawking","year":"1977","journal-title":"Africa Trop Dis Bull"},{"issue":"1","key":"10.1016\/j.ijid.2025.107791_bib0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.aogh.2015.02.539","article-title":"Spotlight on lymphatic filariasis and trachoma in Zimbabwe: assessing baseline data for control program development","volume":"81","author":"Vu","year":"2015","journal-title":"Ann Glob Health"},{"key":"10.1016\/j.ijid.2025.107791_bib0008","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13071-014-0466-x","article-title":"The global distribution and transmission limits of lymphatic filariasis: past and present","volume":"7","author":"Cano","year":"2014","journal-title":"Parasit Vectors"},{"issue":"4","key":"10.1016\/j.ijid.2025.107791_bib0009","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.parepi.2017.08.001","article-title":"Significant decline in lymphatic filariasis associated with nationwide scale-up of insecticide-treated nets in Zambia","volume":"2","author":"Nsakashalo-Senkwe","year":"2017","journal-title":"Parasite Epidemiol Control"},{"issue":"39","key":"10.1016\/j.ijid.2025.107791_bib0010","first-page":"441","article-title":"Global programme to eliminate lymphatic filariasis: progress report, 2015","volume":"91","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"issue":"40","key":"10.1016\/j.ijid.2025.107791_bib0011","first-page":"594","article-title":"Global programme to eliminate lymphatic filariasis: progress report, 2016","volume":"92","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"44","key":"10.1016\/j.ijid.2025.107791_bib0012","first-page":"589","article-title":"Global programme to eliminate lymphatic filariasis: progress report, 2017","volume":"93","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.ijid.2025.107791_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005163","article-title":"Potential value of triple drug therapy with ivermectin, diethylcarbamazine, and albendazole (IDA) to accelerate elimination of lymphatic filariasis and onchocerciasis in Africa","volume":"11","author":"Fischer","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"41","key":"10.1016\/j.ijid.2025.107791_bib0014","first-page":"577","article-title":"Elimination of human onchocerciasis: progress report, 2023\u20132024","volume":"99","year":"2024","journal-title":"Wkly Epidemiol Rec"},{"issue":"10","key":"10.1016\/j.ijid.2025.107791_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005944","article-title":"The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: examples from Ethiopia and Tanzania","volume":"11","author":"Gass","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.ijid.2025.107791_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006325","article-title":"Results of a confirmatory mapping tool for lymphatic filariasis endemicity classification in areas where transmission was uncertain in Ethiopia","volume":"12","author":"Sime","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"unstructured":"WHO-AFRO. Botswana on the search mode for lymphatic filariasis (LF) in the country 2016 [updated 2024-11-16]. Available from: https:\/\/www.afro.who.int\/fr\/node\/1379.","key":"10.1016\/j.ijid.2025.107791_bib0017"},{"issue":"3","key":"10.1016\/j.ijid.2025.107791_bib0018","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1016\/S2214-109X(15)00292-2","article-title":"Reducing the population requiring interventions against lymphatic filariasis in Africa","volume":"4","author":"Bockarie","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.ijid.2025.107791_bib0019","first-page":"88","article-title":"A brief history of tsetse control methods in Zimbabwe and possible effects of climate change on their distribution","volume":"4","author":"Pilossof","year":"2016","journal-title":"Afr J Int Aff Dev"},{"key":"10.1016\/j.ijid.2025.107791_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7007-8-22","article-title":"Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis","volume":"8","author":"Gambhir","year":"2010","journal-title":"BMC Biol"},{"key":"10.1016\/j.ijid.2025.107791_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-015-1152-3","article-title":"Modelling strategies to break transmission of lymphatic filariasis\u2014aggregation, adherence and vector competence greatly alter elimination","volume":"8","author":"Irvine","year":"2015","journal-title":"Parasit Vectors"},{"issue":"4","key":"10.1016\/j.ijid.2025.107791_bib0022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.parepi.2017.08.001","article-title":"Significant decline in lymphatic filariasis associated with nationwide scale-up of insecticide-treated nets in Zambia","volume":"2","author":"Nsakashalo-Senkwe","year":"2017","journal-title":"Parasite Epidemiol Control"},{"issue":"1","key":"10.1016\/j.ijid.2025.107791_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-4-175","article-title":"Adult population as potential reservoir of NTD infections in rural villages of Kwale district, Coastal Kenya: implications for preventive chemotherapy interventions policy","volume":"4","author":"Njenga","year":"2011","journal-title":"Parasit Vectors"},{"issue":"3","key":"10.1016\/j.ijid.2025.107791_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0003642","article-title":"Elimination of lymphatic filariasis in the Gambia","volume":"9","author":"Rebollo","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"13","key":"10.1016\/j.ijid.2025.107791_bib0025","first-page":"121","article-title":"WHO position statement on integrated vector management to control malaria and lymphatic filariasis","volume":"86","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"issue":"3","key":"10.1016\/j.ijid.2025.107791_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008106","article-title":"The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: a cluster randomised trial","volume":"14","author":"Hardy","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"20","key":"10.1016\/j.ijid.2025.107791_bib0027","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJMc1914262","article-title":"Single-dose triple-drug therapy for Wuchereria bancrofti \u2013 5-year follow-up","volume":"382","author":"King","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ijid.2025.107791_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010407","article-title":"Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections","volume":"16","author":"Greene","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.ijid.2025.107791_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009069","article-title":"An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India","volume":"15","author":"Jambulingam","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2025.107791_bib0030","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1093\/inthealth\/ihaa084","article-title":"Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to eliminate Lymphatic Filariasis","volume":"13","author":"Lammie","year":"2020","journal-title":"Int Health"},{"issue":"7","key":"10.1016\/j.ijid.2025.107791_bib0031","first-page":"1","article-title":"Bayesian Network analysis of lymphatic filariasis serology from Myanmar shows benefit of adding antibody testing to post-MDA surveillance","volume":"7","author":"Dickson","year":"2022","journal-title":"Trop Med Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225000153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225000153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T19:58:28Z","timestamp":1741463908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225000153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":31,"alternative-id":["S1201971225000153"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107791","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shrinking the lymphatic filariasis map of Zimbabwe: Reassessing the population requiring treatment through confirmatory mapping","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107791"}}